JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Journal of Neurology, Neurosurgery, and Psychiatry 2006;77:199-202; doi:10.1136/jnnp.2005.066852
Copyright © 2006 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morton, B
Right arrow Articles by Duncan, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morton, B
Right arrow Articles by Duncan, S
Related Collections
Right arrow Patients' choice

PAPER

Sudden unexpected death in epilepsy (SUDEP): don’t ask, don’t tell?

B Morton, A Richardson, S Duncan

Department of Neurology, Greater Manchester Neurosciences Centre, Hope Hospital, Stott Lane, Salford, Manchester, UK

Correspondence to:
Correspondence to:
Dr S Duncan
Department of Neurology, Greater Manchester Neurosciences Centre, Hope Hospital, Stott Lane, Salford, Manchester M6 8 HD, UK; susanduncan{at}compuserve.com

Background: The National Institute for Clinical Excellence in the UK has issued guidelines stating all individuals with epilepsy be given information about sudden unexpected death in epilepsy (SUDEP).

Methods: We conducted a survey of current practice among UK neurologists, using a questionnaire sent to all practising neurologists in the UK listed on the Association of British Neurologists database, asking under what circumstances they told patients about SUDEP.

Results: Of the validated respondents, 5% discussed SUDEP with all patients, 26% with a majority, 61% with a few, and 7.5% with none. The commonest reasons for SUDEP to be discussed were the patient asking about it and the neurologist counselling people with known risk factors for SUDEP.

Conclusions: The variation we found, although not necessarily in tune with the guidelines, reflects the variation in patients’ need for knowledge about their condition.


Abbreviations: NICE, National Institute for Clinical Excellence; SIGN, Scottish Intercollegiate Guidelines Network; SpR, specialist registrar; SUDEP, sudden unexpected death in epilepsy

Keywords: epilepsy; SUDEP




This article has been cited by other articles:


Home page
J. Med. EthicsHome page
Doctors decide disclosure of sudden unexplained death
J. Med. Ethics, May 1, 2006; 32(5): 255 - 255.
[Full Text] [PDF]


Home page
BMJHome page
H. Marcovitch
What's new this month in BMJ Journals
BMJ, April 15, 2006; 332(7546): 904 - 904.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 by the BMJ Publishing Group Ltd.